Table 3.
Immunoreactivity for p40 and p63 in lung SCC and lung ADC
| No. | Cases with the following intensity score |
Cases with the following proportion of immunoreactive cells |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 0%–4% | 5%–25% | 26%–50% | > 50% | ||
| SCC | |||||||||
| p40 | 35 | 6 (17.1) | 3 (8.6) | 1 (2.9) | 25 (71.4) | 2 (5.7) | 2 (5.7) | 0 | 25 (71.4) |
| p63 | 35 | 4 (11.4) | 2 (5.7) | 3 (8.6) | 26 (74.3) | 1 (2.9) | 4 (11.4) | 0 | 26 (74.3) |
| ADC | |||||||||
| p40 | 35 | 33 (94.3) | 2 (5.7) | 0 | 0 | 2 (5.7) | 0 | 0 | 0 |
| p63 | 35 | 13 (37.1) | 9 (25.7) | 8 (22.9) | 5 (14.3) | 9 (25.7) | 6 (17.1) | 5 (14.3) | 2 (5.7) |
Values are presented as number (%).
SCC, squamous cell carcinoma; ADC, adenocarcinoma.